These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

587 related items for PubMed ID: 33973646

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Gabapentin add-on treatment for drug-resistant focal epilepsy.
    Panebianco M, Al-Bachari S, Hutton JL, Marson AG.
    Cochrane Database Syst Rev; 2021 Jan 12; 1(1):CD001415. PubMed ID: 33434292
    [Abstract] [Full Text] [Related]

  • 23. Clonazepam monotherapy for treating people with newly diagnosed epilepsy.
    Brigo F, Igwe SC, Bragazzi NL, Lattanzi S.
    Cochrane Database Syst Rev; 2019 Nov 19; 2019(11):. PubMed ID: 31742671
    [Abstract] [Full Text] [Related]

  • 24. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
    Nevitt SJ, Sudell M, Weston J, Tudur Smith C, Marson AG.
    Cochrane Database Syst Rev; 2017 Jun 29; 6(6):CD011412. PubMed ID: 28661008
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
    Nolan SJ, Marson AG, Weston J, Tudur Smith C.
    Cochrane Database Syst Rev; 2016 Dec 15; 12(12):CD001904. PubMed ID: 27976799
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Carisbamate add-on therapy for drug-resistant focal epilepsy.
    Lu C, Zheng J, Cao Y, Bresnahan R, Martin-McGill KJ.
    Cochrane Database Syst Rev; 2021 Dec 06; 12(12):CD012121. PubMed ID: 34870321
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ, Marson AG, Tudur Smith C.
    Cochrane Database Syst Rev; 2018 Oct 24; 10(10):CD001904. PubMed ID: 30353945
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ, Sudell M, Tudur Smith C, Marson AG.
    Cochrane Database Syst Rev; 2019 Jun 24; 6(6):CD012065. PubMed ID: 31233229
    [Abstract] [Full Text] [Related]

  • 34. Brivaracetam add-on therapy for drug-resistant epilepsy.
    Bresnahan R, Panebianco M, Marson AG.
    Cochrane Database Syst Rev; 2019 Mar 28; 3(3):CD011501. PubMed ID: 30920649
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Oxcarbazepine add-on for drug-resistant focal epilepsy.
    Bresnahan R, Atim-Oluk M, Marson AG.
    Cochrane Database Syst Rev; 2020 Mar 04; 3(3):CD012433. PubMed ID: 32129501
    [Abstract] [Full Text] [Related]

  • 40. Immunomodulatory interventions for focal epilepsy.
    Panebianco M, Walker L, Marson AG.
    Cochrane Database Syst Rev; 2023 Oct 16; 10(10):CD009945. PubMed ID: 37842826
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.